Glutamine metabolism inhibition-related targets and clinical research Glutamine transporter inhibitors As the mechanism of glutamine metabolism in the TME has been continuously explored and revealed, the potential of its related targets in tumor treatment has also received clinical attention
Trusted care
This applies to: 503A compounders: Until April 22, 2025 503B facilities: Until May 22, 2025 Important Caveat: The FDA may still take action regarding violations of any other statutory or regulatory requirements, such as to address findings that a product may be of substandard quality or otherwise unsafe
[DOI] [PubMed] [Google Scholar] 83.Ho YC, Lin HJ, Tsai CH, Chang YC
The system was revealed this past weekend in Dallas, Texas
Fluorescent signals were detected using flow cytometry, and data were analyzed using FlowJo software